Day One Stock Options
| DAWN Stock | USD 12.54 0.14 1.13% |
Day One's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 1.29 with a put-to-call open interest ratio of 0.48 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on April 17th 2025.
Open Interest Against April 17th 2025 Option Contracts
2025-04-17
The chart above shows Day One's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Day One's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Day One's option, there is no secondary market available for investors to trade.
Day One Maximum Pain Price Across 2025-04-17 Option Contracts
Max pain occurs when Day One's market makers reach a net positive position across all Day One's options at a strike price where option holders stand to lose the most money. By contrast, Day One's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Day One
Analyzing Day One's in-the-money options over time can help investors to take a profitable long position in Day One regardless of its overall volatility. This is especially true when Day One's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Day One's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Day One's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Day One lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Day One's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Day One contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Day Stock moves the wrong way.
Day One Biopharmaceu In The Money Call Balance
When Day One's strike price is surpassing the current stock price, the option contract against Day One Biopharmaceuticals stock is said to be in the money. When it comes to buying Day One's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Day One Biopharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Day Current Options Market Mood
Day One's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Day Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Day One's options investors are not very successful. Day One's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Day contract
Base on the Rule 16, the options market is currently suggesting that Day One Biopharmaceuticals will have an average daily up or down price movement of about 0.0806% per day over the life of the 2025-04-17 option contract. With Day One trading at USD 12.54, that is roughly USD 0.0101. If you think that the market is fully incorporating Day One's daily price movement you should consider buying Day One Biopharmaceuticals options at the current volatility level of 1.29%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Day |
Purchasing Day One options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Day calls. Remember, the seller must deliver Day One Biopharmaceuticals stock to the call owner when a call is exercised.
Day One Option Chain
When Day One's strike price is surpassing the current stock price, the option contract against Day One Biopharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Day One's option chain is a display of a range of information that helps investors for ways to trade options on Day. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Day. It also shows strike prices and maturity days for a Day One against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | DAWN250417C00005000 | 1 | 5.0 | 5.3 - 9.0 | 6.5 | In |
Call | DAWN250417C00007500 | 2 | 7.5 | 4.1 - 7.0 | 5.9 | In |
Call | DAWN250417C00010000 | 70 | 10.0 | 2.8 - 4.1 | 2.8 | In |
Call | DAWN250417C00012500 | 228 | 12.5 | 1.6 - 2.4 | 1.65 | Out |
Call | DAWN250417C00015000 | 733 | 15.0 | 0.65 - 1.35 | 0.78 | Out |
Call | DAWN250417C00017500 | 276 | 17.5 | 0.5 - 1.25 | 0.35 | Out |
Call | DAWN250417C00020000 | 109 | 20.0 | 0.0 - 3.7 | 0.28 | Out |
Call | DAWN250417C00022500 | 47 | 22.5 | 0.0 - 0.45 | 0.31 | Out |
Call | DAWN250417C00025000 | 25 | 25.0 | 0.0 - 0.65 | 0.36 | Out |
Call | DAWN250417C00030000 | 2 | 30.0 | 0.0 - 4.1 | 0.75 | Out |
Put | DAWN250417P00005000 | 0 | 5.0 | 0.0 - 4.1 | 4.1 | |
Put | DAWN250417P00007500 | 0 | 7.5 | 0.0 - 0.95 | 0.95 | |
Put | DAWN250417P00010000 | 20 | 10.0 | 0.0 - 1.25 | 0.78 | Out |
Put | DAWN250417P00012500 | 158 | 12.5 | 1.6 - 2.35 | 1.92 | Out |
Put | DAWN250417P00015000 | 523 | 15.0 | 2.4 - 3.9 | 3.45 | In |
Put | DAWN250417P00017500 | 23 | 17.5 | 3.0 - 7.4 | 4.9 | In |
Put | DAWN250417P00020000 | 0 | 20.0 | 5.4 - 8.3 | 5.4 | In |
Put | DAWN250417P00022500 | 0 | 22.5 | 7.7 - 12.0 | 7.7 | In |
Put | DAWN250417P00025000 | 0 | 25.0 | 10.6 - 14.3 | 10.6 | In |
Put | DAWN250417P00030000 | 0 | 30.0 | 15.1 - 19.9 | 15.1 | In |
Day Total Stockholder Equity
Total Stockholder Equity |
|
Day One Corporate Management
| PharmD Chiodin | Chief Officer | Profile | |
| Jaa Roberson | Chief Officer | Profile | |
| Elly MD | Chief Officer | Profile | |
| Adam Dubow | General Counsel | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| Adam JD | General Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Day One Biopharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Day One. If investors know Day will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Day One listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Day One Biopharmaceu is measured differently than its book value, which is the value of Day that is recorded on the company's balance sheet. Investors also form their own opinion of Day One's value that differs from its market value or its book value, called intrinsic value, which is Day One's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Day One's market value can be influenced by many factors that don't directly affect Day One's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Day One's value and its price as these two are different measures arrived at by different means. Investors typically determine if Day One is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Day One's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.